Fostering the development of AI-enhanced technologies to support healthy aging at home for older adults and individuals with Alzheimer’s disease.
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
Accelerating Balance Recovery Using Adaptive EVS Therapy
Investigators:
John Ralston, Neursantys Inc.
VP Nguyen, UMass Amherst
AI-Driven Drug Repurposing to Identify Potential Geroprotectors
Investigators:
Jesse Poganik, Brigham and Women’s Hospital
